Immediate Impact
1 by Nobel laureates 1 from Science/Nature 61 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
Works of Shefali Agarwal being referenced
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
2022
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shefali Agarwal | 398 | 225 | 120 | 179 | 46 | 1.1k | |
| Timo Muhonen | 452 | 282 | 15 | 72 | 54 | 1.1k | |
| Teresa G. Hayes | 222 | 416 | 25 | 359 | 43 | 1.3k | |
| Hiroshi Sunaga | 353 | 403 | 5 | 118 | 72 | 1.2k | |
| Timothy Semple | 139 | 286 | 5 | 59 | 28 | 1.2k | |
| Min Lin | 181 | 388 | 45 | 252 | 70 | 1.1k | |
| Xi Yu | 254 | 498 | 11 | 70 | 60 | 1.3k | |
| Sandra A. Radema | 491 | 244 | 12 | 82 | 37 | 1.0k | |
| Sujata Arora | 514 | 292 | 63 | 287 | 37 | 1.3k | |
| Yasuaki Hirooka | 335 | 589 | 60 | 84 | 86 | 1.4k | |
| Satyanarayana Medicherla | 445 | 554 | 43 | 233 | 30 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...